A new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven®)
- 1 March 2003
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 1 (3), 450-455
- https://doi.org/10.1046/j.1538-7836.2003.00059.x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Thrombin Activatable Fibrinolysis Inhibitor and an Antifibrinolytic PathwayArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Pharmacokinetics of Recombinant Activated Factor VII (rFVIIa)Seminars in Thrombosis and Hemostasis, 2000
- The Treatment of Bleeding in Hemophilic Patients with Inhibitors with Recombinant Factor VIIaSeminars in Thrombosis and Hemostasis, 2000
- Continuous Infusion of Recombinant Factor VIIa in Hemophilic Patients with Inhibitors: Safety, Monitoring, and Cost EffectivenessSeminars in Thrombosis and Hemostasis, 2000
- Efficacy and Safety of Recombinant Factor VIIa in the Prophylaxis of Bleeding in Various Surgical Procedures in Hemophilic Patients with Factor VIII and Factor IX InhibitorsSeminars in Thrombosis and Hemostasis, 2000
- Experience with continuous infusion of recombinant activated factor VII in the Asia-Pacific regionBlood Coagulation & Fibrinolysis, 2000
- Optimal care of inhibitor patients during surgeryEuropean Journal of Haematology, 1998
- Recombinant factor VIIa in continuous infusion during central line insertion in a child with factor VIII high-titre inhibitorHaemophilia, 1998
- Clinical update on the use of recombinant factor VIIPublished by Springer Nature ,1995
- Fibrin in human plasma: Gel architectures governed by rate and nature of fibrinogen activationThrombosis Research, 1994